Teva Pharmaceutical Industries Limited (TEV) — Free Cash Flow Generation Index
Teva Pharmaceutical Industries Limited (TEV) has a Free Cash Flow Generation Index of 0.88x as of December 2025. Free cash flow of €1.02 Billion represents 1% of operating cash flow (€1.16 Billion). See working capital to net assets of Teva Pharmaceutical Industries Limited to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Teva Pharmaceutical Industries Limited Free Cash Flow Generation Index (2015–2025)
Historical FCF Generation Index trend for Teva Pharmaceutical Industries Limited across 11 annual periods. Explore Teva Pharmaceutical Industries Limited (TEV) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Teva Pharmaceutical Industries Limited (2015–2025)
Year-by-year Free Cash Flow Generation Index for Teva Pharmaceutical Industries Limited. For the full company profile including market capitalisation, see market value of Teva Pharmaceutical Industries Limited.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.70x | €1.15 Billion | €1.65 Billion | €501.00 Million | ▲ +15.9% |
| 2024 | 0.60x | €749.00 Million | €1.25 Billion | €498.00 Million | ▲ +14.3% |
| 2023 | 0.53x | €608.00 Million | €1.16 Billion | €549.00 Million | ▼ -19.8% |
| 2022 | 0.66x | €1.04 Billion | €1.59 Billion | €548.00 Million | ▲ +121.6% |
| 2021 | 0.30x | €236.00 Million | €798.00 Million | €562.00 Million | ▼ -43.6% |
| 2020 | 0.52x | €638.00 Million | €1.22 Billion | €578.00 Million | ▲ +76.0% |
| 2019 | 0.30x | €223.00 Million | €748.00 Million | €525.00 Million | ▼ -59.4% |
| 2018 | 0.73x | €1.79 Billion | €2.45 Billion | €651.00 Million | ▼ -38.0% |
| 2017 | 1.18x | €2.63 Billion | €2.23 Billion | €874.00 Million | ▼ -3.9% |
| 2016 | 1.23x | €4.79 Billion | €3.89 Billion | €901.00 Million | ▲ +8.1% |
| 2015 | 1.14x | €6.31 Billion | €5.54 Billion | €772.00 Million | — |